Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




JIB 2010 Focuses on Human Health and Environment

By LabMedica International staff writers
Posted on 14 Oct 2010
The 55th Journées Internationales de Biologie (JIB) will take place on November 2-5, 2010, at the Centre des Nouvelles Industries et Technologies (CNIT; Paris, France). More...
The scientific sessions will focus on improving understanding of the impact of the environment on human health.

The aim of the sessions is to help biologists understand the physiological and pathological phenomena caused by changes in the environment. Chaired by Jean François Bach, permanent secretary of the Academy of Sciences, the scientific program will involve talks on subjects such as biologic response and adaptation mechanisms to the environment; autoimmunity and allergies; the environment and cardiovascular pathologies; the environment and reprotoxins; and nutrition, health and the environment.

The congress will present an opportunity for discussions on the French reform of the medical biology profession. Jean Benoit, President of the SDB [Union of Biologists], commented, "The scale of the task is immense but it gives biologists of all kinds the opportunity to redefine the contours of a profession at the forefront of technological innovation and one that anticipates the major evolutions in medicine.”

For the last three years, the JIB congress has highlighted molecular biology by devoting a space to it at the heart of the show. The molecular biology initiatives pavilion (BioMI) pavilion is dedicated to technologic advances in the process of detecting and curing pathological conditions. This year the JIB will welcome three new companies to the center: Bio Evolution (Italy), Coris Bioconcept (Gembloux, Belgium), and Laboratoires Nephrotek Sas (France).

A scientific session is being organized for BioMI that will be moderated by Prof. Michel Vidaud, head of the biochemistry and molecular genetics department of Beaujon hospital (Paris; France). The program will cover technologic innovations and discussions in areas such as applications of genomic techniques to diagnostics.

More than 1900 congress participants are expected and 96 presentations scheduled. There will be close to 200 exhibitors, including leaders from the in vitro diagnostics (IVD) sector, and an anticipated 10,000 visitors. One hundred and fifty-four new products have been announced and 114 of these will be launched at the show.

Related Links:
Journées Internationales de Biologie
Bio Evolution
Coris Bioconcept
Laboratoires Nephrotek Sas
Beaujon hospital


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.